Protagonist Therapeutics, Inc. (PTGX) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$37,940
Total Return
279.40%
CAGR
30.57%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +4.86% |
| Median | +4.45% |
| Best | +129.27% |
| Worst | -73.15% |
| % of Windows Positive | 61.7% |
1-Year (252 Trading Days)
| Average | +55.05% |
| Median | +64.49% |
| Best | +306.80% |
| Worst | -82.84% |
| % of Windows Positive | 75.5% |
3-Year (756 Trading Days)
| Average | +306.72% |
| Median | +150.60% |
| Best | +1146.41% |
| Worst | -27.59% |
| % of Windows Positive | 81.8% |
Risk Metrics
| Maximum Drawdown | -85.79% |
| Average Drawdown | -37.65% |
| Drawdown Duration | 882 Trading Days |
| Sortino Ratio | 1.21 |
| Calmar Ratio | 0.36 |
| CVaR (5%) | -9.27% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +21.24% (+88.46% ann.) | +$2123.88 | $0.00 | $0.00 | $0.00 |
| 2025 | +126.27% | +$12626.94 | $0.00 | $0.00 | $0.00 |
| 2024 | +68.34% | +$6833.84 | $0.00 | $0.00 | $0.00 |
| 2023 | +110.17% | +$11017.41 | $0.00 | $0.00 | $0.00 |
| 2022 | -68.10% | $6809.94 | $0.00 | $0.00 | $0.00 |
| 2021 | +69.64% | +$6964.29 | $0.00 | $0.00 | $0.00 |
| 2020 | +185.96% | +$18595.75 | $0.00 | $0.00 | $0.00 |
| 2019 | +4.75% | +$475.48 | $0.00 | $0.00 | $0.00 |
| 2018 | -67.64% | $6764.42 | $0.00 | $0.00 | $0.00 |
| 2017 | -5.41% | $541.15 | $0.00 | $0.00 | $0.00 |
| 2016 partial | +87.95% (+412.72% ann.) | +$8794.87 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | August 11, 2016 – February 19, 2020 | -24.62% | -7.71% | $2461.54 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -34.92% | -99.26% | $3492.40 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +242.67% | +625.50% | +$24267.34 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +51.35% | +48.16% | +$5134.76 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -77.07% | -79.06% | $7706.72 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +426.49% | +145.02% | +$42649.47 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +136.52% | +71.96% | +$13652.00 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.